Skip to content

Experiment 2: Understanding Liver Fat Metabolism

Understanding Liver Fat Metabolism: Studies to Understand the Role of Dietary Nutrients on Liver Fat Metabolism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03587753
Acronym
FATOX
Enrollment
24
Registered
2018-07-16
Start date
2018-05-01
Completion date
2021-01-01
Last updated
2022-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fatty Acid Oxidation

Brief summary

There is a largely unsubstantiated thought in the literature that dietary unsaturated enter oxidation pathways preferentially compared to saturated fatty acids. This study is undertaking a direct comparison of the oxidation of dietary saturated and unsaturated fatty acids.

Detailed description

Provided subjects meet the inclusion criteria, then at least one week after the screening visit volunteers will then undertake the first two 'study days'. There will be two study days on separate occasions that will be up to 3 weeks apart. Each study day will be approximately 7 hours in duration. On each study day participants will be given a standardised 'test' meal that contains specially labelled fat molecules (stable-isotope tracer) and then repeated breath and blood samples will be taken over the course of the next 6 hours. The test meal consumed on each 'study day' will be identical in composition with only the specially labelled fat molecules being different (either unsaturated or saturated fat) and these will be given in a random order.

Interventions

OTHERDietary fatty acid partitioning

There is no intervention as such, just a physiological assessment of the partitioning and oxidation of two different types of dietary fatty acids

Sponsors

University of Oxford
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Randomised cross-over

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

Participant is willing and able to give informed consent for participation in the study. Male or Female, aged \>18 and \<65 years BMI \>19 \<35kg/m2 No medical condition or relevant drug therapy known to affect liver metabolism

Exclusion criteria

* • Age \<18 or \>65 years * Body mass index \<19 or \>35kg/m2 * A blood haemoglobin \<120mg/dL * Any metabolic condition or relevant drug therapy * Smoking * History of alcoholism or a greater than recommended alcohol intake * Pregnant or nursing mothers * Women prescribed hormone replacement therapy (HRT) or who have used this within the last 12 months * History of severe claustrophobia * Presence of metallic implants, pacemaker * Haemorrhagic disorders * Anticoagulant treatment

Design outcomes

Primary

MeasureTime frameDescription
Dietary fatty acid partitioning6 hoursThe appearance of the 13Clabelled fatty acid in plasma triglycerides

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026